AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 59 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,871,288 | -20.9% | 2,201,274 | 0.0% | 4.40% | -28.9% |
| Q2 2023 | $37,751,849 | +73.1% | 2,201,274 | +103.6% | 6.19% | +45.6% |
| Q1 2023 | $21,809,297 | -31.2% | 1,081,274 | 0.0% | 4.25% | -24.0% |
| Q4 2022 | $31,681,328 | +99.1% | 1,081,274 | +12.7% | 5.59% | +17.2% |
| Q3 2022 | $15,910,000 | +14.4% | 959,572 | +7.9% | 4.77% | -19.2% |
| Q2 2022 | $13,904,000 | -14.7% | 889,572 | 0.0% | 5.91% | -9.8% |
| Q1 2022 | $16,306,000 | +62.1% | 889,572 | +4.2% | 6.55% | +39.0% |
| Q4 2021 | $10,061,000 | – | 853,330 | – | 4.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |